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ABSTRACT
Objectives: Obesity has been suggested to have a negative influence on procedural outcomes of endometrial cancer 
laparoscopic treatment. Obesity and other possible risk factors of laparoscopic endometrial cancer treatment has not been 
precisely described in the literature. The aim of the study is to determine the factors that have the greatest influence on the 
course of laparoscopic surgery for endometrial cancer, with particular emphasis on the influence of obesity.
Material and methods: The study included 75 females who were treated for endometrial cancer by laparoscopic surgery. 
Preoperative body-mass index (BMI), waist circumference(WC), waist to hip ratio(WHR), and selected anatomical indices 
were measured. The duration of surgery and hospitalization stay, loss of hemoglobin, and procedural-related complications 
served as parameters of in-hospital outcomes.
Results: Multiple linear regression analysis indicate the body mass as most sensitive parameter of obesity which influence 
in-hospital outcomes in patients treated with laparoscopic procedure. Procedural-related complications occurred in the 
group of patients with significantly greater WC and BMI. Multiple linear regression indicates also histological grading (G1–G3), 
external conjugate, intertrochanteric distance as significant risk factors. The multiple linear regression analysis confirmed also 
that implementation of sentinel lymph node procedure is related with decreased hemoglobin loss in patients with cancer 
of endometrium compare to lymphadenectomy without sentinel node biopsy(Est.: 0.488; 95% CI: 0.083–0.892, p = 0.018).
Conclusions: The most sensitive risk factor of in-hospital outcomes in laparoscopic treatment of endometrial cancer is 
body mass. The implementation of the sentinel node procedure is associated with reduced surgery time and reduced 
hemoglobin loss.
Key words: obesity; endometrial cancer; risk factors; minimally invasive therapy; sentinel lymph node procedure; total 
laparoscopic histerectomy; perioperative outcomes
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INTRODUCTION
The most common malignant neoplasm of female re-
productive organs is cancer of the endometrium. Incident 
rates of uterine cancer have increased over successive gen-
erations, especially in countries experiencing rapid socio-
economic transition [1]. The risk of developing endometrial 
cancer by 65 years of age in women ranges from 0.46% 
in low/middle developed countries and 0.92% in highly 
developed countries [2]. The prevalence of a number of 
the established risk factors appears to be rising in most 
parts of the world; obesity, in particular, has doubled in 
last 30 years globally [3]. While conducting a meta-analysis 
of 19 review works and prospective trials, it was found that 
each 5 kg/m2 increase in BMI caused a significant increase 
in the risk of developing endometrial-type cancer (RR 1.59, 
95% CI 1.50–1.68) [4]. In a review conducted among 380 pa-
tients with endometrial cancer, it was noted that morbid 
obesity was connected with higher mortality rate due to 
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causes different than endometrial cancer or disease recur-
rence [5]. Traditionally, obesity was a contraindication to 
laparoscopic procedures and even constituted an exclu-
sion criterion for laparoscopic surgery. Research published 
nearly two decades ago revealed that women qualified for 
laparoscopic management had a substantially lower BMI 
than those operated on using traditional procedures [6]. 
Further studies demonstrated that applying laparoscopic 
procedures in obese patients with endometrial cancer is 
safe and feasible [7–10]. In a recent study, there is evidence 
that the oncological efficiency of laparoscopic systematic 
lymphadenectomy is no less than open-type surgical treat-
ment of patients experiencing intermediate to high-risk 
endometrial cancer [11]. It was also confirmed that sentinel 
nodemapping effectively up-staging patients with low or 
medium risk endometrial cancer and can also be used for 
high-risk histological types (serous cancer, clear cell carci-
noma and carcinosarcoma) [12]. It is possible to distinguish 
factors modifying the perioperative course of endometrial 
cancer treatment with the laparoscopic method, taking into 
account various parameters of obesity, histological type, 
clinical stage of the cancer, type of lymphadenectomy, age 
of patients, comorbidities, pelvic anatomical parameters, 
number of previous abdominal operations. The factors 
with the greatest impact on the perioperative course of 
laparoscopic endometrial cancer has not been described 
in literature on the subject.
The objective of the study was to determine factors 
having the greatest influence on the course of laparoscopic 
surgery for endometrial cancer, with particular emphasis on 
the effect of obesity.
MATERIAL AND METHODS
This project was an observational prospective-type trial 
regarding treatment via laparoscopy. Seventy-five patients 
diagnosed with endometrial cancer qualified for total lapa-
roscopic hysterectomy based on a histopathological ex-
amination of uterine scrapings were included in the study. 
The observation was carried out from January to August 
2019.A pre-operative clinical interview was conducted 
which included questions about age, number of deliveries, 
education in years, previous abdominal surgery and co-
morbidities. The following parameters were determined in 
the preoperative examination: body height and mass, waist 
and hip circumference (cm) using a tape measure, as well as 
dimensions of the pelvic bone measured via a pelvis meter. 
In the study group, body mass index (BMI) and waist-hip ra-
tio (WHR) were calculated for all participants. In accordance 
with the definition provided by the World Health Organiza-
tion, obesity regards a BMI value ≥ 30 kg/m2. Observation 
of patients covered the period from admission to hospital 
to discharge from the hospital and outpatient control in 
the event of postoperative complications. All participants 
gave informed consent prior to conducting the study. The 
study was approved by the ethics committee of the Rzeszów 
University — NO. 4/12/2011.
Eligibility criteria and treatment characteristics
The study included patients qualified for laparoscopic 
treatment who expressed informed consent for laparoscopic 
treatment and expressed informed consent to participate 
in the observational study. Patients were qualified for 
laparoscopic treatment in accordance with current Polish 
guidelines [13].Surgical treatment included: hysterectomy 
with adnexal removal, sentinel node procedure, pelvic and 
para-aortic lymphadenectomy. The sentinel node procedure 
was performed on 34 patients. When the sentinel node 
procedure was performed, 2 mL (1.0 mg/mL) of the dye 
was injected into the cervical stroma, divided between 
a superficial injection of 1–3 mm and a deep injection of 
10–20 mm at 3 and 9 o’clock before entering the manipula-
tor into the uterus. Before hysterectomy, the retroperitoneal 
spaces were developed and fluorescence imaging was used 
for sentinel node detection. Identified sentinel nodes were 
removed and submitted histopathological examination in-
traoperatively. Patients then underwent hysterectomy and 
bilateral salpingo-oophorectomy. According to sentinel 
lymph node procedure (SLNP), all suspicious lymph nodes 
were excised during the surgical procedure, regardless of 
mapping. If no lymph nodes were stained (without map-
ping) on  one side of the pelvis, homologous unilateral pelvic 
lymphadenectomy was performed. Para-aortic lymphad-
enectomy was performed at the surgeon’s discretion. If the 
sentinel node procedure was not performed, the patient was 
subjected to hysterectomy as well as bilateral salpingo-oo-
phorectomy. Then patients underwent systematic pelvic and 
para-aortic lymphadenectomy in some intermediate-risk 
and all high-risk cases. In intermediate-risk cases(G1/G2 en-
dometrioid cancer and myometrial invasion (MI) > 50% or 
G3 endometrioid cancer and MI < 50%) lymphadenectomy 
was considered. In high-risk cases (G3 endometrioid cancer 
and MI > 50%), in all cases of non-endometrioid cancer and 
all cases of clinical stage II, IIIA, IIIB, a lymphadenectomy was 
obligatorily performed [13, 14].
Study endpoints
In the perioperative period, the following selected pa-
rameters were monitored and recognized as predicators of 
in-hospital operative treatment outcomes: surgery duration 
of (/min), hemoglobin loss recognized as the difference in 
serum concentration level prior to surgical treatment and 
on the second day following surgery (in g/dL), the existence 
of procedure-related complications, and hospitalization 
duration (/days). 
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Statistical analysis
The continuous variables analysed in the study are ex-
pressed as mean ± standard deviation, while the categorical 
variables are presented as numbers and percentages. Nor-
mality of distribution was evaluated via the Shapiro-Wilk. 
Continuous variables in selected groups of patients were 
compared using the Welch test, Kruskal-Wallis test, and the 
Student’s t-test when applicable. Categorical variables were 
compared with the chi square test. Univariate and multi-
variate linear regression models were applied for analysis of 
significant predictors regarding selected study endpoints. 
All potential predictors with clinical values were included 
into multiple regression modelling. Best models for predic-
tion of hospitalization duration, procedure duration and 
hemoglobin loss were obtained using backward elimination 
with Akaike Information Criterion as a target. If two vari-
ables were highly correlated (correlation coefficient > 0.7), 
the strongest predictor was selected. Final results were 
presented as point estimates with 95% confidence intervals 
and p-values. R2 coefficients were calculated. Bootstrap 
model validation was performed with 1000 iterations. Model 
assessment was performed by examination of residuals. Sta-
tistical analysis was performed in R version 3.6.2 (R Founda-
tion for Statistical Computing, Vienna, Austria, 2019). The 
p-value < 0.05 was considered statistically significant. 
RESULTS
General characteristics
The study included 75 females treated for endometrial 
cancer in a laparoscopic way. There were 47 (62.7%) obese 
females in the current study (BMI ≥ 30 kg/m2). Patients from 
the obese group were significantly older when compared 
to the non-obese patients (65.8 ± 6.2 vs 59.5 ± 8.3 years, 
p = 0.03). Obese patients originated more often from rural 
areas when compared to non-obese. However those differ-
ence was not significant (44.7% vs 32.1%, p = 0.28). While 
non-obese females were more often uniparous when com-
pared to obese (28.5% vs 10.6%, p = 0.04). Obese females 
suffered more often from diabetes (40.4% vs 3.5%, p = 0.004), 
hypothyroidism (23.4% vs 0%, p = 0.005) and arrhythmias 
(19.1% vs 0%, p = 0.01) when compared to non-obese. 
The general patients’ characteristics in the overall group of 
patients and according to the obesity status is presented in 
Table 1. There were no significant statistical differences in 
the type of procedures used in the groups of patients with 
and without obesity.
Selected antropometric and anatomical indices
Obese and non-obese females differ significantly in all 
the selected parameters of obesity, except for the height, 
which is presented in Table 2. While among anatomical 
parameters, all from the selected were longer among obese 
patients (intertrochanteric, interspinous, intercristal distance 
and external conjugate) when compared to non-obese, 
however statistical significance was achieved for intertro-
chanteric distance(36.08 ± 1.54 vs 35.07 ± 2.71 cm, p = 0.01) 
and intercristal distance (33.08 ± 2.27 vs 31.78 ± 2.78 cm, 
p = 0.03) (Tab. 2). 
Tumor staging and grading 
Most frequently, patients were diagnosed with stage 
I cancer (in accordance with the FIGO classification) and 
then underwent appropriate surgery (Tab. 3). Endometrioid 
cancer was the most frequent histopathological type (96%), 
and most diagnosed at first grade (58.7%). There were no 
significant differences between obese and non-obese pa-
tients (Tab. 3). While the percentage of females diagnosed 
at I A stage of FIGO classification was significantly higher 
among non-obese when compared to obese females (42.8% 
vs 12.7%, p = 0.03). This is presented in Table 3. 
Duration of hospitalization
There was a significant difference in average hos-
pitalization duration, which was notably longer for the 
obese female patients in comparison to the non-obese 
(7.1 ± 1.4 vs 5.4 ± 1.4 days, p < 0.001, Fig. 1C). Univariate 
regression analysis confirmed among predictors related to 
longer hospitalization time: greater waist circumference 
(p < 0.001), waist-hip ratio (p < 0.001), interspinous distance 
(p = 0.03), external conjugate (p = 0.001), higher grading 
(p = 0.03), procedural related complications (p = 0.003), 
diabetes (p = 0.01), hypothyreosis (p = 0.002) and anxiety 
disorders (p = 0.03). The multiple linear regression analysis 
confirmed among significant predictors of hospitalization 
time: body mass (Est.: 0.039; 95% CI: 0.022–0.056, p < 0.001) 
and external conjugate (Est.: 0.363; 95% CI: 0.123–0.603, 
p = 0.003) (Fig. 2). 
Surgery duration
Surgical procedure duration was noted as significant-
ly longer among the obese females when compared to 
non-obese females (98.1 ± 16.6 vs 80.4 ± 15.2 min., p = 0.003) 
(Fig. 1B). The univariate regression analysis revealed among 
factors related significantly to the longer operation time: 
waist-hip ratio (p < 0.001), intertrochanteric distance 
(p = 0.03), interspinous distance (p = 0.03), intercristal dis-
tance (p = 0.02), grading (p = 0.005), FIGO staging (p = 0.001), 
type of lymhadenectomy (p < 0.001), greater number of 
concomitant diseases (p = 0.01), presence of procedural 
related complications (p = 0.005), hypertension (p = 0.007), 
hypothyroidism (p = 0.008), heart failure (p = 0.02) and atrial 
fibrillation (p = 0.02). The significance was confirmed in mul-
tiple linear regression analysis for: body mass t (Est.: 0.473; 
95% CI: 0.23–0.716, p < 0.001), intertrochanteric distance 
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(Est.: 2.225; 95% CI: 0.109–4.341, p = 0.039) and FIGO stag-
ing class IIIC2 vs others (Est.: 39.963; 95% CI: 11.28–68.645, 
p = 0.007). This is presented in Figure 3.
Procedure-related hemoglobin loss
Values of mean hemoglobin loss were significantly high-
er during periprocedural time among obese compared to 
Table 1. Patient’s characteristics




n = 28 p-value
Place of residency
Rural region 30 (40.0) 21 (44.7) 9 (32.1) 0.28
Urban region 28 (37.3) 16 (34.0) 12 (42.8) 0.44
Town > 50,000 residents 17 (22.7) 10 (21.2) 7 (25.0) 0.70
Menstrual status
Before menopause 9 (12.0) 5 (10.6) 4 (14.2) 0.63
After menopause 66 (88) 42 (89.3) 24 (85.7) 0.63
Parity
Nulliparous 5 (7.0) 4 (8.5) 1 (3.5) 0.40
Uniparous 13 (17.0) 5 (10.6) 8 (28.5) 0.04
Multiparous 57 (76.0) 38 (80.8) 19 (67.8) 0.20
Co-morbidities 
Diabetes mellitus 20 (26.7) 19 (40.4) 1 (3.5) 0.004
Hypertension 34 (45.3) 25 (53.2) 9 (32.1) 0.07
Coronary artery disease 10 (13.3) 8 (17.0) 2 (7.1) 0.22
History of venous occlusive disease 3 (5.2) 3 (6.4) 0 (0) 0.17
Arrhythmias 9 (12) 9 (19.1) 0 (0) 0.01
Prior cerebral stroke 4 (5.3) 3 (6.3) 1 (3.5) 0.60
Chronic heart failure 4 (5.3) 3 (6.3) 1 (3.5) 0.60
Bronchial asthma 6 (8.0) 5 (3.2) 1 (3.5) 0.27
Chronic pulmonary obstructive disease 8 (10.7) 5 (3.2) 3 (10.7) 0.99
Hyperthyroidism 6 (8.0) 4 (8.5) 2 (7.1) 0.83
Hypothyroidism 11 (14.7) 11 (23.4) 0 (0) 0.005
Cholelithiasis 6 (8.4) 5 (10.6) 1 (3.5) 0.27
Diathesis urica 4 (5.6) 2 (7.1) 2 (7.1) 0.59
Osteoarthritis 9 (12.6) 6 (12.7) 3 (10.7) 0.79
Chronic pancreatitis 8 (10.7) 6 (12.7) 2 (7.1) 0.44
Chronic gastritis 6 (8.0) 4 (8.5) 2 (7.1) 0.83
Peptic ulcer disease 6 (8.0) 5 (10.6) 1 (3.5) 0.27
Anxiety disorders 4 (5.3) 4 (8.5) 0 (0) 0.11
Table 2. Selected antropometric and anatomical indices




n = 28 p-value
Weight [kg] 84.08 ± 20.30 94.25 ± 18.19 67.00 ± 8.23 < 0.001
Height [cm] 161.72 ± 8.72 161.59 ± 5.06 161.39 ± 4.63 0.86
Body-mass index [kg/m2] 31.13 ± 7.29 35.99 ± 6.30 25.65 ± 2.60 < 0.001
Waist circumference [cm] 109.21 ± 18.78 118.34 ± 16.63 93.89 ± 9.69 < 0.001
Hip circumference [cm] 114.37 ± 20.20 122.76 ± 14.13 100.28 ± 20.65 < 0.001
Waist-hip ratio 0.94 ± 0.05 0.96 ± 0.04 0.90 ± 0.05 < 0.001
Intertrochanteric diameter [cm] 35.11 ± 4.37 36.08 ± 1.54 35.07 ± 2.71 0.01
Interspinous diameter [cm] 27.28 ± 1.94 27.48 ± 1.94 26.92 ± 1.86 0.23
Intercristal diameter [cm] 32.60 ± 2.57 33.08 ± 2.27 31.78 ± 2.78 0.03
External conjugate [cm] 21.86 ± 1.35 22.06 ± 1.19 21.53 ± 1.52 0.10
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non-obese patients (1.05 ± 0.21 vs 0.82 ± 0.2 g/dL, p = 0.006) 
(Fig. 1A). The univariate regression analysis demonstrated 
that among significant predictors related to the greater 
hemoglobin loss during the procedure there were: tumor 
staging (p = 0.002), presence of procedural related com-
plications (p < 0.001), diabetes (p = 0.05), hypothyroidism 
(p = 0.007) and heart failure (p = 0.007). The multiple linear 
regression analysis confirmed among factors significantly 
related to hemoglobin loss: body mass (Est.: 0.008; 95% CI: 
0.006–0.011, p < 0.001), sentinel lymph node procedure 
(Est.: 0.488; 95% CI: 0.083–0.892, p = 0.018), pelvic lymphad-
enectomy (Est.: 0.535; 95% CI: 0.136–0.935, p = 0.009), and 
pelvic and para-aortic lymphadenectomy (Est.: 0.62; 95% 
CI: 0.197–1.044, p = 0.004) (Fig. 4). 
Procedure-related complications
Five perioperative complications were noted: postop-
erative wound infection with impaired healing process in 
one of the patients, infection of vaginal wound with need 
of antibacterial systemic therapy in two patients, conver-
sion to open surgery involved with abdominal obesity and 
pre-peritoneal entry and insufflation, omental damage 
and bleeding in one patient. All of these complications 
occurred in obese females. The differences in parameters 
of obesity between group with and without perioperative 
complications are statistically significant (BMI — 37.13 vs 
37.43 p = 0.00002, WC — 106.91 vs 141.40 p = 0.00003, 
WHR — 0.93 vs 0.97 p = 0.004). We did not perform regres-
sion analysis due to the fact that were not able to create 
Table 3. Tumor characteristics according to the obesity status




n = 28 p-value
Histopathological type
Endometrioid
G1 44 (58.7) 27 (57.4) 17 (60.7) 0.78
G2 25 (33.3) 14 (29.8) 11 (39.2) 0.39
G3 3 (4.0) 3 (6.4) 0 (0) 0.17
Clear-cell 1 (1,3) 1 (2.1) 0 (0) 0.43
Serous 1 (1,3) 1 (2.1) 0 (0) 0.43
Adenosquamous 1 (1.3) 1 (2.1) 0 (0) 0.43
Non-epithelial 0 (0) 0 (0) 0 (0) –
Staging according to FIGO 
classification
Stage I
A 18 (24) 6 (12.7) 12 (42.8) 0.03
B 35 (46.7) 24 (51.0) 11 (39.2) 0.32
Stage II 13 (17.3) 9 (19.1) 4 (14.2) 0.59
Stage III
A 3 (4.0) 2 (4.2) 1 (3.5) 0.88
B 4 (5.3) 4 (8.5) 0 (0) 0.11
C1 1 (2.1) 1 (2.1) 0 (0) 0.43
C2 0 (0) 0 (0) 0 (0) –
Stage IV
A 1 (2.1) 1 (2.1) 0 (0) 0.43
B 0 (0) 0 (0) 0 (0) –
Figure 1. A. Duration of hospitalization according to the obesity status; B. Duration of the operation according to the obesity status;  
C. Haemoglobin loss after the procedure according to the obesity status
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dedicated model, which was caused by lower number of 
complications in comparison to the number of assessed 
indices and number of their subclasses.
DISCUSSION
The general findings of this study are that patients with 
obesity experienced longer hospitalization as well as surgery 
duration, higher loss of hemoglobin during the periproce-
dural period. A further observation worth highlighting is 
that non-obese subjects were diagnosed with stage IA en-
dometrial cancer (in accordance with FIGO classification) 
more frequently than obese patients. What is more, larger 
waist-hip ratio, higher grading and FIGO staging as well as 
greater range of lymphadenectomy were confirmed among 
the factors related to prolonged surgery time. Predictors of 
duration of hospitalization were greater waist circumfer-
ence, waist-hip ratio, external conjugate, higher grading, 
and procedural related complications. A high correlation to 
hemoglobin loss were noticed for waist circumstance and 
BMI (r = 0.58 for WC and r = 0.59 for BMI). However, multiple 
Figure 2. Predictors of the duration of hospitalization — multivariate linear regression analysis
Figure 3. Predictors of the duration of operation — multivariate linear regression analysis
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linear regression analysis indicated weight and range of 
lymphadenectomy as a factors significantly related to hemo-
globin loss. Patients with procedure-related complications 
were characterized by greater waist circumference and BMI. 
Multiple linear regression analysis indicated also that great-
er external conjugate was related to longer hospitalization 
and greater intertrochanteric distance was related to great-
er operative time. These observations may result from the 
fact that larger pelvic dimensions occurred in significantly 
more obese patients, or from the assumption that greater 
distances in laparoscopy hinder precision of surgery Yu et 
al. [10] noted that laparoscopic surgery is safe to use in 
morbidly obese women with endometrial cancer. Total 
laparoscopic hysterectomy with lymphadenectomy was also 
reported to be a safe procedure with benefits of application 
instead of laparotomy due to: shortened hospital stay, 
fewer complications, less hemoglobin loss and a better 
cosmetic result [15–17]. According to Malinowski et al. [18], 
a total laparoscopic hysterectomy with lymphadenectomy 
is a better alternative method than laparotomy that is char-
acterized by a significantly smaller percentage of complica-
tions, better cosmetic results and a shorter hospital stay 
when performed by an experienced surgeon. Minimal ac-
cess surgery appeared to be the preferred approach being 
associated with a lower pain score, a shorter hospitalization, 
and an earlier resumption of daily activities when compared 
with open surgery in randomized controlled trials [19, 20]. 
The average duration of surgery and hospitalization, as well 
as hemoglobin loss in the group subjected to endometrial 
cancer surgical treatment via laparoscopic procedures are 
similar to results achieved by other centers [15, 21]. In this 
trial, greater waist circumference may be connected with 
longer hospitalization and surgery duration. Among other 
natural explanations, the more complicated surgical proce-
dure for obese compared to non-obese patients may be 
given. In the case of gynecological surgery via laparoscopy 
or using robotic apparatus, the navel may be considered 
a primary entry-point in the abdominal area for the reason 
that it is the thinnest part of the abdominal wall [22]. The 
navel’s anatomic location: at aortic bifurcation level in 
non-obese females — is a significant characteristic point 
allowing the surgeon to more easily pinpoint critical in-
tra-peritoneal structures during abdominal access via lapa-
roscopy. Along with the increase in rates of obesity , par-
ticularly, the amount of women characterized by central 
adiposity what initiates a shift in this anatomic correlation. 
The navel is translocated caudally via the panniculus along 
with the increase in central adiposity, while the relationship 
between umbilicus and intra-peritoneal structures under-
goes change. Abdominal-related obesity also causes an in-
crease in entry depth and furthermore, increases the dan-
gers of pre-peritoneal entry as well insufflation with follow-
ing conversion to laparotomy. Nonetheless, overall risks 
related to injury for laparoscopic entry are low when per-
formed by an experienced surgeon [23]. About 50% of all 
laparoscopy-related injuries occur at the time of initial ab-
dominal trocar placement [24, 25]. The chances of laparo-
scopic injury may be higher among women with abdominal 
obesity. The left upper quadrant approach was first de-
scribed by Palmer. It is frequently applied when entry via 
the umbilicus is challenging or contraindicated, or in cases 
when periumbilical adhesions, myomatous uteri (organ per-
Figure 4. Predictors of the extent of haemoglobin loss according — multivariate linear regression analysis
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foration risk), large ovarian cysts (mass rupture) are sus-
pected, or in the two final trimesters of pregnancy (compli-
cation related to excessive bleeding) [22]. In the case of 
patients with abdominal obesity, the skin to peritoneum 
distance is increased. This may complicate initial trocar in-
troduction. The advantages of visualizing open laparoscopy 
(Hasson technique) are restricted due to increased adipos-
ity inherent among obese patients, which can further lead 
to difficulties in maintaining pneumoperitoneum [26]. 
Minimal abdominal invasive surgery may be challenging or 
hazardous in the case of overweight or obese subjects, es-
pecially when endometrial cancer is combined with ab-
dominal obesity. The left upper quadrant entry can be a safe, 
reliable alternative for entry through the umbilical area in 
high-risk patients [27]. Greater waist circumference as well 
as BMI were noted in patients who experienced proce-
dure-related complications. Complications following sur-
gery may be early or late. The most commonly noted early 
complications after laparoscopic surgical gynecology are: 
conversion to open surgery, pre-peritoneal entry, subcuta-
neous edema, omental trauma, excessive bleeding, damage 
to the bladder, ureteral trauma, as well as intestinal perfora-
tion. The most frequently observed complications following 
surgical procedures include infection, difficulty in healing 
of the wound , thromboembolic and cardiovascular com-
plications, respiratory and renal failure, gastrointestinal 
obstruction, disorders concerning urination and urogenital 
as well as intestinal fistulas. The co-morbidity rates regard-
ing obesity and endometrial cancer can be linked with high 
procedure-related complications. Laparoscopic hysterec-
tomy and bilateral salpingo-oophorectomy have been dem-
onstrated to be the surgical technique of choice for women 
with endometrial cancer in three large randomized con-
trolled trials [16, 17, 28]. Surgical staging is safe and feasible 
in a morbidly obese patient when using a minimally invasive 
approach. In addition, this approach is associated with 
lower estimated blood loss, length of hospital stay, and 
fewer perioperative complications. However, longer operat-
ing room time (minutes), estimated blood loss (mL) and 
length of hospital stay were associated with obese patients 
compared to non-obese [29]. In this study, a correlation was 
found between obesity (WC and BMI) and perioperative 
complication occurrence rate. There were statistically sig-
nificant differences with regard to parameters for the com-
parative patient group experiencing complications (5 sub-
jects). In the case of abdominal obesity, chronic inflamma-
tion or metabolic disturbances can also be considered as 
part of the reason for the observed complications following 
surgery, which may include: infection, difficulty in wound 
healing, circulatory or respiratory problems. In our trial, 
univariate regression analysis indicated that waist circum-
stance and waist-hip ratio have the highest predictive value 
for the analysed parameters for in-hospital outcomes among 
patients with endometrial cancer. However, multivariant 
regression indicates that body mass is the factor determin-
ing in-hospital outcomes. It is worth noting that the great-
er range of lymphadenectomy without sentinel lymph node 
procedure is a factor related to longer duration of operation 
and greater hemoglobin loss. The recent application of sen-
tinel lymph node mapping has allowed for high feasibility 
and safety, as well accuracy in the evaluation of nodal me-
tastasis. In a recent study, evidence could be found indicat-
ing that laparoscopic systematic lymphadenectomy is not 
of lower oncological efficient than open surgery when treat-
ing patients with intermediate- or high-risk endometrial 
cancer [31]. In a number of numerous studies, authors have 
come to the conclusion that sentinel lymph node mapping 
may be considered a precise alternative for systemic lym-
phadenectomy on determining the nodal spread in ECs at 
an early stage, while being cost-effective for treatment of 
patients low-risk endometrial cancer. In recent studies, it 
has also been shown that sentinel lymph node mapping 
allows upstaging in low- or intermediate-risk endometrial 
cancer patients for whom adjuvant therapy may be omitted. 
This strategy may be also applied in high-risk histological 
cancer types (serous carcinoma, clear cell carcinoma, and 
carcinosarcoma) [32]. Women with endometrial cancer 
staged with the sentinel lymph node procedure were more 
likely to undergo adjuvant treatment when compared to 
women staged with systemic lymphadenectomy. A decrease 
in surgery duration and a decreased rate of lymphatic ede-
ma strongly motivate the sentinel lymph biopsy concept in 
patients with high-risk endometrial cancer [33].Our study 
confirmed that implementation of sentinel lymph node 
procedure is related with reduced hemoglobin loss and 
operative time in patients with endometrial cancer compare 
to lymphadenectomy without sentinel node biopsy.
Limitations
This study may be considered developmental due to it 
being conducted on a small sample size. Furthermore, in the 
conducted analysis, attention was paid to evaluating trends 
and correlations between individual indicators and the re-
sults of treatment among a relatively small patient group.
CONCLUSIONS
Obesity is related to a longer duration of procedure and 
hospitalization, and greater hemoglobin loss associated 
with the laparoscopic treatment of endometrial cancer. Our 
study indicate the body mass as most sensitive parameter 
of obesity which influence in-hospital outcomes in patients 
treated with laparoscopic procedures. Abdominal obesity pa-
rameters, especially waist circumference significantly affect 
in-hospital treatment results. Some anatomical indices such 
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as intertrochanteric distance and external conjugate are also 
significant risk factors for laparoscopic treatment of endo-
metrial cancer. There are statistically significant differences in 
parameters of obesity between two groups with or without 
procedural complications. Sentinel lymph node procedure is 
related with decreased operative time and hemoglobin loss. 
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